Global Aortic Aneurysm Market Growth, Share, Size, Trends and Forecast (2025 - 2031)

By Type;

Abdominal Aortic Aneurysm (AAA) and Thoracic Aortic Aneurysm (TAA).

By Product;

Stent Grafts, Catheters and Others.

By Treatment;

Endovascular Aneurysm Repair (EVAR) and Open Surgical Repair (OSR).

By End User;

Hospitals And Clinics, Ambulatory Surgery Centers (ASCs) and Others.

By Geography;

North America, Europe, Asia Pacific, Middle East and Africa and Latin America - Report Timeline (2021 - 2031).
Report ID: Rn101253904 Published Date: March, 2025 Updated Date: April, 2025

Introduction

Global Aortic Aneurysm Market (USD Million), 2021 - 2031

In the year 2024, the Global Aortic Aneurysm Market was valued at USD 2,690.64 million. The size of this market is expected to increase to USD 4,671.40 million by the year 2031, while growing at a Compounded Annual Growth Rate (CAGR) of 8.2%.

Certainly! Here's an introduction structured into four paragraphs for the global aortic aneurysm market:

Aortic aneurysm, a condition characterized by the weakening and ballooning of the aorta—the body’s main artery—is a critical medical concern globally. The prevalence of aortic aneurysms has been steadily rising, driven primarily by aging populations and lifestyle factors such as smoking and hypertension. This increase has spurred significant interest and investment in the development of effective diagnostic tools and treatment options, driving the growth of the global aortic aneurysm market.

The market landscape for aortic aneurysm encompasses a range of diagnostic modalities and treatment approaches tailored to the diverse needs of patients. Diagnostic techniques include imaging studies such as ultrasound, CT scans, and MRI, which enable healthcare providers to accurately assess the size and location of aneurysms. Early detection plays a crucial role in managing aortic aneurysms effectively, as timely intervention can help prevent life-threatening complications such as rupture.

In terms of treatment, surgical interventions and minimally invasive procedures are at the forefront of medical advancements. Traditional open surgery for aortic aneurysm repair has gradually given way to endovascular repair (EVAR), a less invasive procedure that involves inserting a stent graft to reinforce the weakened artery wall. EVAR has gained popularity due to its reduced recovery times and lower procedural risks compared to open surgery, thereby driving its adoption and contributing to the expansion of the market.

The global aortic aneurysm market is also shaped by ongoing research and development efforts aimed at improving treatment outcomes and patient care. Innovations in biomaterials for stent grafts, advancements in imaging technology for better visualization of aneurysms, and personalized medicine approaches are key areas of focus. Moreover, collaborations between healthcare providers, research institutions, and pharmaceutical companies are pivotal in accelerating the pace of innovation and expanding the therapeutic options available to patients worldwide. As the understanding of aortic aneurysms continues to evolve, so too does the landscape of the market, promising continued growth and improved outcomes for patients in the years to come.

  1. Introduction
    1. Research Objectives and Assumptions
    2. Research Methodology
    3. Abbreviations
  2. Market Definition & Study Scope
  3. Executive Summary
    1. Market Snapshot, By Type
    2. Market Snapshot, By Product
    3. Market Snapshot, By Treatment
    4. Market Snapshot, By End User
    5. Market Snapshot, By Region
  4. Global Aortic Aneurysm Market Dynamics
    1. Drivers, Restraints and Opportunities
      1. Drivers
        1. Aging Population
        2. Technological Advancements
        3. Increasing Awareness
        4. Rising Healthcare Expenditure
      2. Restraints
        1. High Treatment Costs
        2. Lack of Skilled Surgeons
        3. Stringent Regulatory Framework
        4. Limited Access to Healthcare
      3. Opportunities
        1. Emerging Markets Expansion
        2. Development of Minimally Invasive Techniques
        3. Personalized Medicine Approaches
        4. Collaborative Research Initiatives
    2. PEST Analysis
      1. Political Analysis
      2. Economic Analysis
      3. Social Analysis
      4. Technological Analysis
    3. Porter's Analysis
      1. Bargaining Power of Suppliers
      2. Bargaining Power of Buyers
      3. Threat of Substitutes
      4. Threat of New Entrants
      5. Competiitve Rivalry
  5. Market Segmentation
    1. Global Aortic Aneurysm Market, By Type, 2021 - 2031 (USD Million)
      1. Abdominal Aortic Aneurysm (AAA)
      2. Thoracic Aortic Aneurysm (TAA)
    2. Global Aortic Aneurysm Market, By Product, 2021 - 2031 (USD Million)
      1. Stent Grafts
      2. Catheters
      3. Others
    3. Global Aortic Aneurysm Market, By Treatment, 2021 - 2031 (USD Million)
      1. Endovascular Aneurysm Repair (EVAR)
      2. Open Surgical Repair (OSR)
    4. Global Aortic Aneurysm Market, By End User, 2021 - 2031 (USD Million)
      1. Hospitals & Clinics
      2. Ambulatory Surgery Centers (ASCs)
      3. Others
    5. Global Aortic Aneurysm Market, By Geography, 2021 - 2031 (USD Million)
      1. North America
        1. United States
        2. Canada
      2. Europe
        1. Germany
        2. United Kingdom
        3. France
        4. Italy
        5. Spain
        6. Nordic
        7. Benelux
        8. Rest of Europe
      3. Asia Pacific
        1. Japan
        2. China
        3. India
        4. Australia & New Zealand
        5. South Korea
        6. ASEAN (Association of South East Asian Countries)
        7. Rest of Asia Pacific
      4. Middle East & Africa
        1. GCC
        2. Israel
        3. South Africa
        4. Rest of Middle East & Africa
      5. Latin America
        1. Brazil
        2. Mexico
        3. Argentina
        4. Rest of Latin America
  6. Competitive Landscape
    1. Company Profiles
      1. Medtronic Plc
      2. Cook Medical
      3. Terumo Medical Corporation
      4. Microport Scientific Corporation
      5. MAQUET Holding B.V. & Co. KG
      6. Endologix, Inc.
      7. W. L. Gore & Associates
      8. Lombard Medical Limited
  7. Analyst Views
  8. Future Outlook of the Market